Page 1441 - Williams Hematology ( PDFDrive )

1416 Part X: Malignant Myeloid Diseases Chapter 88: Acute Myelogenous Leukemia 1417

36. Willems E, Valdes-Socin H, Betea D, et al: Association of acute leukemia and autoim- 69. Fokin AA, Robicsek F: Poland’s syndrome revisited. Ann Thorac Surg 74:2218,
mune polyendocrine syndrome in two kindreds. Leukemia 17:1912, 2003. 2002.
37. Lichtenstein P, Holm NV, Verkasalo PK, et al: Environmental and hereditable factors 70. Pianigiani E, DeAloe G, Andreassi A, et al: Rothmund-Thomson syndrome (Thom-
in causation of cancer—Analyses of cohorts of twins from Sweden, Denmark, and son type) and myelodysplasia. Pediatr Dermatol 18:422, 2001.
Finland. N Engl J Med 343:78, 2000. 71. Duker NJ: Chromosome breakage syndromes and cancer. Am J Med Genet 115:125,
38. Risch N: The genetic epidemiology of cancer. Interpreting family and twin studies and 2002.
their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers 72. Hayani A, Suarez CR, Molnar Z, et al: Acute myeloid leukemia in a patient with Seckel
Prev 10:733, 2001. syndrome. J Med Genet 31:148, 1994.
39. Hemminki K, Vaittinen P, Dong C, Easton D: Sibling risks in cancer: Clues to recessive 73. Boocock GR, Morrison JA, Popovic M, et al: Mutations in SBDS are associated with
or X-linked genes? Br J Cancer 84:388, 2001. Shwachman-Diamond syndrome. Nat Genet 33:97, 2003.
40. Germeshausen M, Ballmaier M, Welte K: Implications of mutations in hematopoietic 74. Rujkijyanont P, Beyene J, Wei K, et al: Leukaemia-related gene expression in bone
growth factor receptor genes in congenital cytopenias. Ann N Y Acad Sci 938:305, 2001. marrow cells from patients with the preleukaemic disorder Shwachman-Diamond
41. Tonelli R, Scardovi AL, Pession A, et al: Compound heterozygosity for two different syndrome. Br J Haematol 137:537, 2007.
amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in 75. Mitsui T, Kawakami T, Sendo D, et al: Successful unrelated donor bone marrow trans-
congenital amegakaryocytic thrombocytopenia (CAMT). Hum Genet 107:225, 2000. plantation for Shwachman-Diamond syndrome with leukemia. Int J Hematol 79:189,
42. Li FP, Hecht F, Kaiser-McCaw B, et al: Ataxia-pancytopenia: Syndrome of cerebellar 2004.
ataxia, hypoplastic anemia, monosomy 7, and acute myelogenous leukemia. Cancer 76. Yamada T, Tsurumi H, Murakami N, et al: Werner’s syndrome developing acute
Genet Cytogenet 4:189, 1981. megakaryoblastic leukemia with der(1;7). Rinsho Ketsueki 38:28, 1997.
43. Gonzales-del Angel A, Cervera M, Gomez L, et al: Ataxia-pancytopenia syndrome. 77. Tao LC, Stecker E, Gardner HA: Werner’s syndrome and acute myeloid leukemia.
Am J Med Genet 90:252, 2000. CMAJ 105:951, 1971.
44. German J: Bloom’s syndrome: Incidence, age of onset, and types of leukemia in the 78. Muftuoglu M, Oshima J, von Kobbe C, et al: The clinical characteristics of Werner
Bloom’s syndrome registry, in Genetics in Hematologic Disorders, edited by Bartsocas syndrome: Molecular and biochemical diagnosis. Hum Genet 124:369, 2008.
CS, Loukopoulos D, p 241. Hemisphere, Washington, 1992. 79. Sharathkumar A, Kirby M, Freedman M, et al: Malignant hematological disorders in
45. Poppe B, Van Limbergen H, Van Roy N, et al: Chromosomal aberrations in Bloom children with Wolf-Hirschhorn syndrome. Am J Med Genet 119A:194, 2003.
syndrome patients with myeloid malignancies. Cancer Genet Cytogenet 128:39, 2001. 80. Gonzalez CH, Durkin-Stamm MV, Geimer NF, et al: The WT syndrome—A “new”
46. Freedman MH, Alter BP: Risk of myelodysplastic syndrome and acute myeloid leuke- autosomal dominant pleiotropic trait of radial/ulnar hypoplasia with high risk of
mia in congenital neutropenia. Semin Hematol 39:128, 2002. bone marrow failure and/or leukemia. Birth Defects Orig Artic Ser 13:31, 1977.
47. Aprikyan AA, Kutyavin T, Stein S, et al: Cellular and molecular abnormalities in 81. Kristinsson SY, Bjorkholm M, Hultcrantz M, et al: Chronic immune stimulation
severe congenital neutropenia predisposing to leukemia. Exp Hematol 31:372, 2003. might act as a trigger for the development of acute myeloid leukemia or myelodys-
48. Rosenberg PS, Alter BP, Link DC, et al: Neutrophil elastase mutations and risk of plastic syndromes. J Clin Oncol 29: 2897, 2011.
leukaemia in severe congenital neutropenia. Br J Haematol 140:210, 2008. 82. Wu SP, Costello R, Hofmann JN, et al: MGUS prevalence in a cohort of AML patients.
49. Link DC, Kunter G, Kasai Y, et al: Distinct patterns of mutations occurring in de Blood 122:294, 2013.
novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 83. Fialkow PH, Singer JW, Adamson JW, et al: Acute nonlymphocytic leukemia. Hetero-
110:1648, 2007. geneity of stem cell origin. Blood 57:1068, 1991.
50. Shinawi M, Erez A, Shardy DL, et al: Syndromic thrombocytopenia and predisposi- 84. Ferraris AM, Broccia G, Meloni T, et al: Clonal origin of cells restricted to monocytic
tion to acute myelogenous leukemia caused by constitutional microdeletions on chro- differentiation in acute nonlymphocytic leukemia. Blood 64:817, 1984.
mosome 21q. Blood 112:1042, 2008. 85. Turhan AG, Lemoire FB, Debert C, et al: Highly purified primitive hematopoietic
51. Janov AJ, Leong T, Nathan DG, Guinan EC: Diamond-Blackfan anemia: Natural stem cells are PML-RARA negative and generate nonclonal progenitors in acute pro-
history and sequelae of treatment. Medicine (Baltimore) 75:77, 1996. myelocytic leukemia. Blood 85:2154, 1995.
52. Vlachos A, Klein G, Lipton J: The Blackfan-Diamond anemia registry: Tool for inves- 86. Van Lom K, Hagenmeijer A, Vandekerckhove F, et al: Clonality analysis of hemato-
tigating the epidemiology and biology of Diamond-Blackfan anemia. Pediatr Hematol poietic cell lineages in acute myeloid leukemia and translocation (8;21): Only myeloid
Oncol 23:377, 2001. cells are part of malignant clone. Leukemia 11:202, 1997.
53. Forestier E, Izraeli S, Beverloo B, et al: Cytogenetic features of acute lymphoblastic and 87. Goardon N, Marchi E, Atzberger A, et al: Coexistence of LMPP-like and GMP-like
myeloid leukemias in pediatric patients with Down syndrome: An iBFM-SG study. leukemia stem cells in acute myeloid leukemia. Cancer Cell 19:138, 2011.
Blood 111:1575, 2008. 88. Majeti R, Weissman IL: Human acute myelogenous leukemia stem cells revisited:
54. Puumala SE, Ross JA, Olshan AF, et al: Reproductive history, infertility treatment, There’s more than meets the eye. Cancer Cell 19:9, 2011.
and the risk of acute leukemia in children with down syndrome: A report from the 89. Pandolfi A, Barreyro L, Steidl U: Concise review: Preleukemic stem cells: Molecular
Children’s Oncology Group. Cancer 110:2067, 2007. biology and clinical implications of the precursors to leukemia stem cells. Stem Cells
55. Andrade-Machado R, Machado-Rojas A, de la Torre-Santos ME: Dubowitz syn- Transl Med 2:143, 2013.
drome, polymyositis, and aleucemic myeloblastic leukemia. A new association. Rev 90. Jan M, Snyder TM, Ryan M, et al: Clonal evolution of preleukemic hematopoietic
Neurol 35:500, 2001. stem cells precedes human acute myeloid leukemia. Sci Transl Med 149:149ra118,
56. Savage SA, Alter BP: The role of telomere biology in bone marrow failure and other 2012.
disorders. Mech Ageing Dev 129:35, 2008. 91. Shlush LI, Zandi S, Mitchell A, et al: Identification of pre-leukaemic haematopoietic
57. Röth A, Baerlocher GM: Dyskeratosis congenita. Br J Haematol 141:412, 2008. stem cells in acute leukaemia. Nature 506:328, 2014.
58. Segel GB, Lichtman MA: Familial (inherited) leukemia, lymphoma, and myeloma. 92. Chan SM, Majeti R: Role of DNMT3A, TET2, and IDH-1/2 mutations in pre-leukemic
Blood Cells Mol Dis 32:246, 2004. stem cells in acute myeloid leukemia. Int J Hematol 98:648, 2013.
59. Owen CJ, Toze CL, Koochin A, et al: Five new pedigrees with inherited RUNX1 muta- 93. Welch JS, Ley TJ, Link DC, et al: The origin and evolution of mutations in acute mye-
tions causing familial platelet disorder with propensity to myeloid malignancy (FPD/ loid leukemia. Cell 150:264, 2012.
AML). Blood 112:4639, 2008. 94. Parkin B, Ouillette P, Li Y, et al: Clonal evolution and devolution after chemotherapy
60. Minelli A, Maserati E, Rossi G, et al: Familial platelet disorder with propensity to acute in adult acute myelogenous leukemia. Blood 121:369, 2013.
myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acqui- 95. Swiggers SJJ, Kuijpers MA, de Cort MJM, et al: Critically short telomeres in acute
sition of clonal chromosome anomalies. Genes Chromosomes Cancer 40:165, 2004. myeloid leukemia with loss or gain of parts of chromosomes. Genes Chromosomes
61. Rosenberg PS, Greene MH, Alter BP: Cancer incidence in persons with Fanconi ane- Cancer 45:247, 2006.
mia. Blood 101:822, 2003. 96. Yamada O, Oshimi K, Motoji, et al: Telomeric DNA in normal and leukemic blood
62. Rosenberg PS, Alter BP, Ebell W: Cancer risks in Fanconi anemia: Findings from the cells. J Clin Invest 95:1117, 1995.
German Fanconi Anemia Registry. Haematologica 93:511, 2008. 97. Look AT: Oncogene transcription factors in human acute leukemias. Science 278:1059,
63. Dickinson RE, Milne P, Jardine L, et al: The evolution of cellular deficiency in GATA2 1997.
mutation. Blood 123:863, 2014. 98. Pabst T, Mueller BU: Transcriptional dysregulation during myeloid transformation in
64. Polychronopoulou S, Tsatsopoulou A, Papadhimitriou SI, et al: Myelodysplasia and AML. Oncogene 26:6829, 2007.
Naxos disease: A novel pathogenetic association? Leukemia 16:2335, 2002. 99. Kelly LM, Gilliland DG: Genetics of myeloid leukemias. Annu Rev Genomics Hum
65. Kratz CP, Antonietti L, Shannon KM, et al: Acute myeloid leukemia associated with Genet 3:179, 2002.
t(8;21) or trisomy 8 in children with neurofibromatosis type 1. Pediatr Hematol Oncol 100. Damm F, Heuser M, Morgan M, et al: Integrative prognostic risk score in acute mye-
25:343, 2003. loid leukemia with normal karyotype. Blood 117:4561, 2011.
66. Lurgaespada DA, Brannan CI, Shaughnessy JD, et al: The neurofibromatosis type 1 101. Pastore F, Duforu A, Benthaus T, et al: Combined molecular and clinical prognostic
(NF1) tumor suppressor gene and myeloid leukemia. Curr Top Microbiol Immunol index for relapse and survival in cytogenetically normal acute myeloid leukemia.
211:233, 1996. J Clin Oncol 32:1586, 2014.
67. Bader-Meunier B, Tchernia G, Miélot F, et al: Occurrence of myeloproliferative disor- 102. Li Z, Herold T, He C, et al: Identification of a 24-gene prognostic signature that
der in patients with Noonan syndrome. J Pediatr 130:885, 1997. improves the European Leukemia Net risk classification of acute myeloid leukemia:
68. Bentires-Alj M, Paez JG, David FS, et al: Activating mutations of the Noonan An international collaborative study. J Clin Oncol 31:1172, 2013.
syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute 103. Marcucci G, Yan P, Maharry K, et al: Epigenetics meets genetics in acute myeloid
myelogenous leukemia. Cancer Res 64:8816,2004. leukemia: Clinical impact of a novel seven-gene score. J Clin Oncol 32:548, 2013.

Kaushansky_chapter 88_p1373-1436.indd 1416 9/21/15 11:02 AM